NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 262 filers reported holding NOVOCURE LTD in Q4 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $8,023,000 | -33.3% | 60,700 | -12.7% | 0.07% | -29.6% |
| Q4 2020 | $12,026,000 | -23.9% | 69,500 | -51.1% | 0.10% | -33.8% |
| Q3 2020 | $15,806,000 | +21.2% | 142,000 | -35.4% | 0.15% | +19.4% |
| Q2 2020 | $13,040,000 | +3.6% | 219,900 | +17.7% | 0.12% | -17.3% |
| Q1 2020 | $12,586,000 | -63.7% | 186,900 | -54.6% | 0.15% | -51.5% |
| Q4 2019 | $34,719,000 | -4.7% | 412,000 | -15.4% | 0.31% | -4.0% |
| Q3 2019 | $36,418,000 | -35.3% | 487,000 | -45.3% | 0.32% | -25.6% |
| Q2 2019 | $56,276,000 | +18.2% | 890,015 | -10.0% | 0.43% | +18.0% |
| Q1 2019 | $47,611,000 | +11.0% | 988,390 | -22.9% | 0.37% | -0.8% |
| Q4 2018 | $42,910,000 | -30.8% | 1,281,675 | +8.4% | 0.37% | -10.0% |
| Q3 2018 | $61,964,000 | +33.2% | 1,182,525 | -20.4% | 0.41% | +32.2% |
| Q2 2018 | $46,509,000 | – | 1,485,900 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |